First Approval for Fast-Acting Lispro for Diabetes; EU OKs Oral Semaglutide First Approval for Fast-Acting Lispro for Diabetes; EU OKs Oral Semaglutide
EMA panel recommends approval of oral GLP-1 agonist semaglutide for type 2 diabetes. It has also given the thumbs up to a mealtime, or fast-acting form, of insulin lispro for adults with diabetes.International Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 31, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Alert Source Type: news

Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Insulin donation, along with $2 million in grants to relief agencies, extends program launched in 2018 INDIANAPOLIS, Jan. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Starting this month, Eli Lilly and Company (NYSE: LLY) will donate at least ... Biopharmaceuticals, Drug Delivery, Endocrinology Eli Lilly, KwikPen, insulin, Humalog, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 28, 2020 Category: Pharmaceuticals Source Type: news

Eli Lilly to offer half-priced versions of two more insulin products
Eli Lilly and Co said on Tuesday it plans to sell two versions of insulin products at half their current U.S. list prices, eight months after it started selling a half-priced version of its widely-used Humalog injection. (Source: Reuters: Health)
Source: Reuters: Health - January 14, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Collaboration Makes the Diabetes World Go & #039;Round
In the world of diabetes technologies, collaboration is the name of the game. Medtronic and Novo Nordisk are working together to integrate insulin dosing data from future Novo Nordisk smart insulin pens into continuous glucose monitoring (CGM) devices from Medtronic, such as the Guardian Connect system shown above. At the same time, Abbott and Sanofi will be working on tools that combine Abbott's FreeStyle Libre technology with Sanofi's insulin dosing information. "We see incredible power in combining a variety of data points to drive insights that help people living with diabetes make more informed decisions around managi...
Source: MDDI - September 17, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Half-Price Version of Humalog Insulin Available
The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, (Source: WebMD Health)
Source: WebMD Health - May 23, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Now Available
Title: Half-Price Version of Humalog Insulin Now AvailableCategory: Health NewsCreated: 5/22/2019 12:00:00 AMLast Editorial Review: 5/23/2019 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - May 23, 2019 Category: Endocrinology Source Type: news

Eli Lilly's lower-priced insulin goes on sale amid drug price debate
A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. (Source: CNN.com - Health)
Source: CNN.com - Health - May 22, 2019 Category: Consumer Health News Source Type: news

Half-Price Version of Humalog Insulin Now Available
WEDNESDAY, May 22, 2019 -- A half-price version of Humalog insulin is now available in the United States, Eli Lilly said Wednesday. The company ' s generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2019 Category: Pharmaceuticals Source Type: news

Eli Lilly's half-price insulin goes on sale, but critics say it's still too costly
Eli Lilly's lower-cost version of its Humalog insulin still costs much more than insulin sold outside the U.S. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 22, 2019 Category: Consumer Health News Source Type: news

Lilly selling half-price version of popular Humalog insulin
A half-price version of Eli Lilly's popular Humalog insulin is now available under the name Insulin Lispro, after the drugmaker promised a more affordable option amid soaring insulin prices. (Source: ABC News: Health)
Source: ABC News: Health - May 22, 2019 Category: Consumer Health News Tags: Health Source Type: news

Medical News Today: What's the difference between Humalog and NovoLog?
Humalog and NovoLog are types of medication that can help control blood sugar levels in people with diabetes. Learn about the differences between them here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 9, 2019 Category: Consumer Health News Tags: Diabetes Source Type: news

Generic Humalog; 23andMe T2D Test; Menopause Ads Blocked
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 15, 2019 Category: Cardiology Source Type: news

How Much Difference Will Eli Lilly's Half-Price Insulin Make? How Much Difference Will Eli Lilly's Half-Price Insulin Make?
Lilly is rolling out a half-priced version of its insulin Humalog that will be sold as a generic.Kaiser Health News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 13, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Eli Lilly Offers Lower-Priced Version of its Lispro Insulin Eli Lilly Offers Lower-Priced Version of its Lispro Insulin
The new ' authorized generic ' is the same product as Humalog, offered through a Lilly subsidiary at about half the list price to patients paying out of pocket.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 5, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Drug Maker To Sell Cheaper Version of Insulin
A cheaper version of Eli Lilly's most popular insulin drug, Humalog, is being introduced by the drug maker. (Source: WebMD Health)
Source: WebMD Health - March 4, 2019 Category: Consumer Health News Source Type: news